Home » News » Technology Solutions » Ventana receives FDA clearance for Ki-67 (30-9) image analysis

Ventana receives FDA clearance for Ki-67 (30-9) image analysis

Tuesday, March 6, 2012

The FDA has granted Ventana Medical Systems, a member of the Roche Group, 510(k) clearance for its Ventana Companion Algorithm Ki-67 (30-9) image analysis application used with the Ventana iScan Coreo Au scanner running Virtuoso software.

The 510(k) clearance covers all components of the Ventana workflow solution used together, including the company’s BenchMark slide stainer, Ki-67 (30-9) clone, detection systems, slide scanner and image management software.

The decision makes Ventana the only company offering an FDA cleared Ki-67 image analysis algorithm for determining Ki-67 expression levels in breast cancer patients.

Ventana also received FDA clearance for the digital read application that allows the pathologist to interpret Ki-67 (30-9) stained slides as images on a computer monitor with the Ventana iScan Coreo Au scanner and Virtuoso software.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!